The nomogram, using RELA, PRKAB1, TNFRSF1A, CAMKK2, and CPT1B, was next confirmed as a reliable predictive model for epilepsy that would bring patients a net clinical benefit when the threshold probability ranged from 0.1 to 1.0. This evidence concerns the gene CPT1B and epilepsy.